Related Experiment Videos
[Antiphospholipid antibodies and the central nervous system]
1Service d'Urgences cérébro-vasculaires, Hôpital de la Salpêtrière, Paris.
Revue Neurologique
|January 1, 1992
Summary
Anti-phospholipid antibodies (APA) are linked to blood clots, particularly in arteries and veins. Neurological issues in APA are often ischemic, like strokes and TIAs, necessitating further research for better treatment.
Area of Science:
- Immunology
- Neurology
- Vascular Medicine
Context:
- Anti-phospholipid antibodies (APA) are implicated in thrombo-embolic events.
- APA can be secondary to systemic diseases or part of primary anti-phospholipid syndrome.
- Neurological manifestations are predominantly ischemic, including infarcts and transient ischemic attacks.
Purpose:
- To elucidate the mechanisms of cerebral ischemia in primary anti-phospholipid syndrome.
- To inform therapeutic strategies through accurate diagnosis.
- To gather data on prognosis and management via a prospective controlled study.
Summary:
- Anti-cardiolipin antibodies and lupus anticoagulants, types of APA, are associated with arterial and venous thrombo-embolic manifestations.
- Neurological presentations in APA are typically ischemic, such as subcortical infarcts and transient ischemic attacks.
- Understanding the mechanisms of cerebral ischemia is crucial for guiding treatment choices in primary anti-phospholipid syndrome.
Impact:
- Improved diagnostic approaches for APA-related neurological conditions.
- Enhanced therapeutic strategies for patients with primary anti-phospholipid syndrome.
- Better patient outcomes through informed prognosis and management.